SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-043678
Filing Date
2021-11-09
Accepted
2021-11-09 19:25:09
Documents
2
Period of Report
2021-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10242
2 EX-24 DOCUMENT attachment1.htm EX-24 3515
  Complete submission text file 0000899243-21-043678.txt   15104
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 PLAYER POINT DRIVE THE WOODLANDS TX 77382
Business Address
Kuriakose Emil (Reporting) CIK: 0001892413 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36644 | Film No.: 211393793